Systematic review and meta-analysis: impact of anti-viral therapy on portal hypertensive complications in HBV patients with advanced chronic liver disease.

Yuanyuan KongTingting LvMin LiLianghui ZhaoTongtong MengShanshan WuWei WeiQian ZhangSha ChenHong YouSabela LensHitoshi YoshijiSven FrancqueEmmanouil TsochatzisShiv K SarinMattias MandorferJi-Dong Jianull null

Published in: Hepatology international (2022)

NA therapy lowers the risk of portal hypertension-related complications, including variceal bleeding, HCC, and liver transplantation/death.

Keyphrases

blood pressure
risk factors
hepatitis b virus
sars cov
stem cells
atrial fibrillation